LoPriore Vincent S 4

What Happened Vincent S. LoPriore, a reported 10% owner of Hepion Pharmaceuticals (HEPA), made two purchases on April 21, 2026: 5,000,000 shares at $0.04 each ($200,000) and 1,250,000 shares at $0.04 each ($50,000), for a total acquisition of 6,250,000 shares costing approximately $250,000. Both entries are reported as purchases (code P), which is a direct buy of stock rather than a sale or derivative transaction.

Key Details

• Transaction date: 2026-04-21 (both purchases) — reported on Form 4 filed 2026-04-27 (filed 6 days after the transaction).
• Prices and amounts: 5,000,000 shares @ $0.04 ($200,000) and 1,250,000 shares @ $0.04 ($50,000).
• Total acquired: 6,250,000 shares for ~$250,000.
• Shares owned after transaction: Not specified in the supplied filing details.
• Footnotes: F1 — LoPriore is Managing Member of Gravitas Capital LP and can vote/dispose of securities held by that entity. F2 — LoPriore is trustee and beneficiary of the Pension Plan and can vote/dispose of securities held by that plan.
• Timeliness: The Form 4 was filed six days after the transactions (appears late relative to the typical 2-business-day Form 4 requirement), which delays public disclosure.

Context

• These were purchases (generally viewed as a more informative signal than routine sales), but filings don’t explain motivation. Purchases appear to have been made by entities/vehicles tied to LoPriore (see footnotes), so this reflects control/institutional ownership activity rather than a typical executive trading disclosure.
• No options exercised, gifts, or tax-withholding events are reported here.